5/16
02:13 pm
pbla
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
High
Report
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
5/15
04:20 pm
pbla
Panbela Provides Business Update and Reports Q1 2024 Financial Results [Yahoo! Finance]
High
Report
Panbela Provides Business Update and Reports Q1 2024 Financial Results [Yahoo! Finance]
5/15
04:10 pm
pbla
Panbela Provides Business Update and Reports Q1 2024 Financial Results
High
Report
Panbela Provides Business Update and Reports Q1 2024 Financial Results
5/6
08:00 am
pbla
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Low
Report
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
5/1
04:15 pm
pbla
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
Medium
Report
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
4/30
08:00 am
pbla
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
Low
Report
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
4/22
08:13 am
pbla
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 [Yahoo! Finance]
High
Report
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 [Yahoo! Finance]
4/22
08:00 am
pbla
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
High
Report
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
4/18
08:17 am
pbla
Panbela Announces Poster Presentation at American Association for Cancer Research: [Yahoo! Finance]
Medium
Report
Panbela Announces Poster Presentation at American Association for Cancer Research: [Yahoo! Finance]
4/18
08:00 am
pbla
Panbela Announces Poster Presentation at American Association for Cancer Research:
Medium
Report
Panbela Announces Poster Presentation at American Association for Cancer Research:
4/16
05:29 pm
pbla
Panbela Announces Transfer to OTCQB Market
Low
Report
Panbela Announces Transfer to OTCQB Market
3/27
12:11 pm
pbla
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $25.00 price target on the stock.
Medium
Report
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $25.00 price target on the stock.
3/27
11:04 am
pbla
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/26
04:30 pm
pbla
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results [Yahoo! Finance]
Medium
Report
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results [Yahoo! Finance]
3/26
04:10 pm
pbla
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
Medium
Report
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
3/12
04:15 pm
pbla
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
Low
Report
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024